Tris Pharma, a CMO for Pfizer, hit with FDA warning letter for ADHD drug, morphine solution

12th April 2018 Uncategorised 0

Tris Pharma, a New Jersey-based CMO that manufactures the ADHD drug Quillivant for Pfizer, was hit with a warning letter by the FDA that cited significant violations.

More: Tris Pharma, a CMO for Pfizer, hit with FDA warning letter for ADHD drug, morphine solution
Source: fierce